02Jan 2018


  • Assistant Professor Department of Surgery Eras Lucknow Medical College (ELMCH).
  • Assistant Professor Dept of Anatomy, ELMCH.
  • Professor, Dept of Anatomy, ELMCH.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Background: Prostate cancer is one of the most common malignancies diagnosed in men & is the most common cancer found in men older than 60 years. One third of all men older than 50 years have a latent form of prostate cancer that may progress to life threatening Prostate cancer. In this study all the precancerous lesions were more common in the higher age groups (60-69 and 70-79 years). Material And Methods: The present study has been performed on 100 patients in the department of Surgery , Eras Lucknow medical college and hospital. The age of the patients varied from 40-80 years. Maximum proportion of patients (34%) were aged between 60-69 yrs followed by 70-79 yrs (30%). There were 12% patients in age grp 40-49 yrs and 24% were in the age group of 50-59 years. Thus it was seen that the complaints of lower urinary tract system or prostatic disease were common in higher age group. Results: In this study all the precancerous lesions were more common in the higher age groups (60-69 and 70-79 years). However , no statistically significant association between type of lesion and age could be established in this study (p=0.267). Studying the histopathology only peripheral and central zones were seen to be involved. Peripheral zone was involved in 4/5 (80%) cases while central zone was involved in 1/5 (20%) cases Overall, in the present study, PIN was found to be an efficacious marker for prognosis of prostate carcinoma.

  1. Harvard Prostate Knowledge.
  2. McNeal, JE. Origin and development of carcinoma in prostate. Cancer 1969;23:24.
  3. Drago, JR, Mastofi, FK, Lee, F. Introductory remarks and workshop summary. Urology 1992;39:2.
  4. Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural pattern of high grade prostatic intraepithelial neoplasia. Hum Pathol. Mar 1993;24(3):298-310.
  5. Bostwik DG. Prostatic intraepithelial neoplasia. Current Urology reports 2000;1(1):65-70.
  6. Bostwik DG, Neumann R, Qian J, Cheng L. Reversibility of Prostatic intraepithelial Neoplasia. Implications for chemoprevention. Eur Urol 1999;35:492-495.
  7. Shahrokh F Shariat, Claus G Roehrbom. Using Biopsy to Detect Prostate Cancer. Urology2008;10(4):262-280.
  8. Ximing J Yang. Precancerous lesions of prostate:Pathology and clinical implications. Uptodate Literture review July 2017.
  9. Stanley A Brosman.Precancerous lesion of the Prostate.Medscape Feb 2017.
  10. Sunny L, Yeole BB, Kurkure AP, Hakama M, Shiri R,Mathews S, Shastri NG, Advani SH. Cumulative risk and trends in prostate cancer incidence in Mumbai, India. Asian Pac J Cancer Prev. 2004 Oct-Dec;5(4):401-5.
  11. Wills M, Hamper U, Partin A, Epstein J. Incidence of high grade prostatic intraepithelial neoplasia in sextant needle biopsy specimens. Urology 1997;49(3):367-373.
  12. Orozco R, O Dowd G, Kunnel B, Miller MC,Veltri RW. Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States. Urology. Feb 1998;51(2):186-95.
  13. Novis DA, Zarbo RJ, Valenstein PA. Diagnostic uncertainty expressed in prostate needle biopsies. A college of American Pathologists Q-probes Study of 15,753 prostate needle biopsies in 332 institutions. Arch Pathol Lab Med. Aug 1999;123(8):687-92.

[S. S. Haider, Tahsin Munsif and Vineeta Tewari. (2018); PRECANCEROUS LESIONS OF PROSTATE A CLINICO-PATHOLOGICAL STUDY. Int. J. of Adv. Res. 6 (1). 1-5] (ISSN 2320-5407). www.journalijar.com

Dr Tahsin Munsif
Assistant Professor, Anatomy, Eras Lucknow Medical College & Hospital


Article DOI: 10.21474/IJAR01/6176        DOI URL: http://dx.doi.org/10.21474/IJAR01/6176

Share this article